Odyssey Health (ODYY) EBITDA Margin (2014 - 2016)

Odyssey Health has disclosed EBITDA Margin across 3 years of filings, most recently posting 207.5% for Q3 2016.

• Quarterly EBITDA Margin changed N/A year-over-year to 207.5% in Q3 2016, while the trailing twelve-month figure through Apr 2017 was 972.18% (down 67667.0% YoY) and the FY2016 annual result came in at 196.43%, down 13582.0% from the prior year.
• EBITDA Margin declined to 207.5% in Q3 2016, from 13.88% in the prior quarter.
• Across five years, EBITDA Margin topped out at 13.88% in Q2 2016 and bottomed at 235.48% in Q2 2015.
• The 3-year median for EBITDA Margin is 49.03% (2015), against an average of 106.97%.
• The widest YoY moves for EBITDA Margin: up 22159 bps in 2016, down 22159 bps in 2016.
• Odyssey Health's EBITDA Margin stood at 28.98% in 2014, then slumped by 712 bps to 235.48% in 2015, then increased by 12 bps to 207.5% in 2016.
• According to Business Quant data, EBITDA Margin over the past three periods registered 207.5%, 13.88%, and 235.48% for Q3 2016, Q2 2016, and Q2 2015 respectively.